Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2009 Aug;53(8):3552-60.
doi: 10.1128/AAC.00418-09. Epub 2009 Jun 8.

Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria

Affiliations

Besifloxacin, a novel fluoroquinolone, has broad-spectrum in vitro activity against aerobic and anaerobic bacteria

Wolfgang Haas et al. Antimicrob Agents Chemother. 2009 Aug.

Abstract

The antibacterial spectrum of besifloxacin, a novel fluoroquinolone recently approved for treatment of ocular infections, was studied using 2,690 clinical isolates representing 40 species. Overall, besifloxacin was the most potent agent tested against gram-positive pathogens and anaerobes and was generally equivalent to comparator fluoroquinolones in activity against most gram-negative pathogens. Besifloxacin demonstrated potent, broad-spectrum activity, which was particularly notable against gram-positive and gram-negative isolates that were resistant to other fluoroquinolones and classes of antibacterial agents.

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Chemical structure of besifloxacin hydrochloride.

References

    1. American Academy of Ophthalmology. Conjunctivitis, preferred practice pattern. 2003. American Academy of Ophthalmology, San Francisco, CA.
    1. Asbell, P. A., K. A. Colby, S. Deng, P. McDonnell, D. M. Meisler, M. B. Raizman, J. D. Sheppard, Jr., and D. F. Sahm. 2008. Ocular TRUST: nationwide antimicrobial susceptibility patterns in ocular isolates. Am. J. Ophthalmol. 145:951-958. - PubMed
    1. Blondeau, J. M., L. Brunner, and S. Norton. 2006. Abstr. 46th Intersci. Conf. Antimicrob. Agents Chemother., abstr. F1-2001.
    1. Blondeau, J. M., L. Brunner, and S. Norton. 2006. Abstr. 46th Intersci. Conf. Antimicrob. Agents Chemother., abstr. F1-2002.
    1. Brunner, L., S. Norton, and J. M. Blondeau. 2007. Abstr. 17th Eur. Congr. Clin. Microbiol. Infect. Dis., abstr. P1679.

Publication types

MeSH terms